We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Cancer Researchers Use Fluorescent Tags to Track Dispersion of Tumors During Metastasis

By LabMedica International staff writers
Posted on 23 Aug 2015
Print article
Image: Multicolored metastasis in the peritoneal lining of the abdomen comprised of red and yellow fluorescent cells demonstrating that pancreatic cancer spreads through interactions between different groups of cells (Photo courtesy of Dr. Ravi Maddipati, University of Pennsylvania).
Image: Multicolored metastasis in the peritoneal lining of the abdomen comprised of red and yellow fluorescent cells demonstrating that pancreatic cancer spreads through interactions between different groups of cells (Photo courtesy of Dr. Ravi Maddipati, University of Pennsylvania).
A novel mouse cancer model was developed in which tumor cells with different mutations were labeled with specific fluorescent signals that allowed them to be traced by their unique colors as they left the site of the primary tumor and established themselves in other locations in the body.

In order to learn whether metastasis in a mouse model depended on multiple cell types or single clones, investigators at the University of Pennsylvania (Philadelphia, USA) used a variety of fluorescent proteins to tag and track different pancreatic cancer cells as they entered the bloodstream and spread to distant organs.

They reported in the July 24, 2015, online edition of the journal Cancer Discovery that mutations in the Kras and p53 genes generated differently colored tumor cell populations. The mice eventually developed tumors at secondary sites including the liver, lung, peritoneum, and diaphragm. These metastases often comprised cells from tumor cell populations displaying at least two different colors. By backtracking, the investigators showed that these multicolored growths originated from circulating tumor cells that occurred as clusters of different colored cancer cells.

In some secondary sites (lung and liver), despite colonization by multicolored clusters, subsequent growth of a single colored tumor derived from physiological factors in the organ in which they now resided.

"These results provide an unprecedented window into the cellular dynamics of tumor evolution and suggest that interactions between subpopulations of tumor cell types contribute to metastatic progression from initial tumors," said senior author Dr. Ben Z. Stanger, professor of gastroenterology at the University of Pennsylvania. "The finding that metastases are frequently polyclonal and that subsequent cellular behavior is site-dependent also gives us insight into the origins and evolution of clonal diversity in metastatic disease. If cells do cooperate during metastasis, what is the molecular basis for their communication, and can we hit that? The work also reinforces the importance of finding tumor cell clusters in the blood as a mechanism of detecting cancer metastasis earlier."

Related Links:

University of Pennsylvania


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.